1-6 of 6
Sandra J. Strauss
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT045: Prospective precision medicine trial of crizotinib (C) in patients (pts) with advanced, inoperable inflammatory myofibroblastic tumor (IMFT) with and without ALK alterations: EORTC phase II study 90101 "CREATE"

Free
Patrick Schoffski, Jozef Sufliarsky, Hans Gelderblom, Jean-Yves Blay, Sandra J. Strauss, Silvia Stacchiotti, Piotr Rutkowski, Lars H. Lindner, Michael G. Leahy, Antoine Italiano, Nicolas Isambert, Maria Debiec-Rychter, Raf Sciot, Thomas Van Cann, Sandrine Marréaud, Axelle Nzokirantevye, Sandra Collette, Agnieszka Wozniak
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): CT045.
https://doi.org/10.1158/1538-7445.AM2018-CT045
Published: 01 July 2018
View article titled, Abstract CT045: Prospective precision medicine trial of crizotinib (C) in patients (pts) with advanced, inoperable inflammatory myofibroblastic tumor (IMFT) with and without ALK alterations: EORTC phase II study 90101 "CREATE"
Journal Articles

Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma

Free
Jozef Ban, Dave N.T. Aryee, Argyro Fourtouna, Wietske van der Ent, Max Kauer, Stephan Niedan, Isidro Machado, Carlos Rodriguez-Galindo, Oscar M. Tirado, Raphaela Schwentner, Piero Picci, Adrienne M. Flanagan, Verena Berg, Sandra J. Strauss, Katia Scotlandi, Elizabeth R. Lawlor, Ewa Snaar-Jagalska, Antonio Llombart-Bosch, Heinrich Kovar
Journal: Cancer Research
Series: Author Choice
Cancer Res (2014) 74 (22): 6578–6588.
https://doi.org/10.1158/0008-5472.CAN-14-1736
Published: 13 November 2014
View article titled, Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma
Open the PDF for Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma in another window
Includes: Supplementary data
Journal Articles

Abstract PR10: Inhibition of deacetylase SIRT1 offers a novel treatment option in metastatic Ewing sarcoma

Free
Jozef Ban, Argyrou Fourtouna, Isidro Machado, Stephan Niedan, Ewa Snaar-Jagalska, Dave NT Aryee, Maximilian Kauer, Marco Alberghini, Adrienne Flanagan, Katia Scotlandi, Sandra J. Strauss, Elisabeth R. Lawlor, Antonio Llombart-Bosch, Heinrich Kovar
Journal: Cancer Research
Cancer Res (2014) 74 (20_Supplement): PR10.
https://doi.org/10.1158/1538-7445.PEDCAN-PR10
Published: 09 October 2014
View article titled, Abstract PR10: Inhibition of deacetylase SIRT1 offers a novel treatment option in metastatic Ewing sarcoma
Journal Articles

Abstract 431: ErbB4 is a novel driver of metastasis and anoikis resistance in Ewing's sarcoma

Free
Ariadna Mendoza-Naranjo, Daniel H. Wai, Jason E. Farrar, Qingsong Zhu, Priti Mistry, Nikola Lazic, Fernanda Rocha Rojas Ayala, Isabela Werneck da Cunha, Robert J. Arceci, Fernando A. Soares, Timothy J. Triche, Sandra J. Strauss, Poul Hb Sorensen
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 431.
https://doi.org/10.1158/1538-7445.AM2012-431
Published: 15 April 2012
View article titled, Abstract 431: ErbB4 is a novel driver of metastasis and anoikis resistance in Ewing's sarcoma
Journal Articles

Abstract 1636: ErbB4 is a new therapeutic target for metastasis and anoikis resistance in Ewing's sarcoma

Free
Ariadna Mendoza-Naranjo, Pitri Mistry, Nikola Lazic, Sandra J. Strauss, Poul HB Sorensen
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1636.
https://doi.org/10.1158/1538-7445.AM2011-1636
Published: 15 April 2011
View article titled, Abstract 1636: ErbB4 is a new therapeutic target for metastasis and anoikis resistance in Ewing's sarcoma
Journal Articles

The Proteasome Inhibitor Bortezomib Acts Independently of p53 and Induces Cell Death via Apoptosis and Mitotic Catastrophe in B-Cell Lymphoma Cell Lines

Free
Sandra J. Strauss, Karen Higginbottom, Simone Jüliger, Lenushka Maharaj, Paul Allen, David Schenkein, T. Andrew Lister, Simon P. Joel
Journal: Cancer Research
Cancer Res (2007) 67 (6): 2783–2790.
https://doi.org/10.1158/0008-5472.CAN-06-3254
Published: 15 March 2007
View article titled, The Proteasome Inhibitor Bortezomib Acts Independently of p53 and Induces Cell Death via Apoptosis and Mitotic Catastrophe in B-Cell Lymphoma Cell Lines
Open the PDF for The Proteasome Inhibitor Bortezomib Acts Independently of p53 and Induces Cell Death via Apoptosis and Mitotic Catastrophe in B-Cell Lymphoma Cell Lines in another window